Search

Equasens

Fermé

40.5 -3.23

Résumé

Variation du prix de l'action

24h

Actuel

Min

40.35

Max

41.8

Chiffres clés

By Trading Economics

Revenu

17M

Ventes

116M

P/E

Moyenne du Secteur

18.054

Rendement du dividende

2.84

Marge bénéficiaire

14.879

Employés

1,400

EBITDA

116M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.84%

Prochains Résultats

30 mars 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

649M

Ouverture précédente

43.73

Clôture précédente

40.5

Equasens Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

16 janv. 2026, 23:29 UTC

Actions en Tendance

Stocks to Watch: Atossa Therapeutics, Union Pacific

16 janv. 2026, 22:48 UTC

Acquisitions, Fusions, Rachats

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16 janv. 2026, 22:43 UTC

Acquisitions, Fusions, Rachats

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16 janv. 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16 janv. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

16 janv. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Auto & Transport Roundup: Market Talk

16 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 janv. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

16 janv. 2026, 21:48 UTC

Market Talk
Acquisitions, Fusions, Rachats

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16 janv. 2026, 21:41 UTC

Market Talk
Acquisitions, Fusions, Rachats

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16 janv. 2026, 21:38 UTC

Acquisitions, Fusions, Rachats

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16 janv. 2026, 20:44 UTC

Résultats

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16 janv. 2026, 20:42 UTC

Market Talk

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16 janv. 2026, 20:28 UTC

Market Talk

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16 janv. 2026, 19:12 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

16 janv. 2026, 18:53 UTC

Market Talk

Global Crude Supply Enough to Absorb Any Iran Disruption -- Market Talk

16 janv. 2026, 18:41 UTC

Market Talk

Netflix's Ad Business Seen as Primary Revenue Driver in 2026 -- Market Talk

16 janv. 2026, 18:31 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 410 -- Market Talk

16 janv. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

16 janv. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 janv. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

16 janv. 2026, 17:03 UTC

Market Talk

Global Equities Roundup: Market Talk

16 janv. 2026, 17:03 UTC

Market Talk

All Eyes on Guidance for European Big Pharma Earnings Season -- Market Talk

16 janv. 2026, 16:32 UTC

Market Talk
Acquisitions, Fusions, Rachats

Sanofi Needs Dealmaking to Offset Pipeline Disappointments -- Market Talk

16 janv. 2026, 16:20 UTC

Market Talk

Global Equities Roundup: Market Talk

Equasens prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Equasens

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat